Recurrent Ovarian Carcinoma Active Not Recruiting Phase 2 Trials for Everolimus (DB01590)

IndicationStatusPhase
DBCOND0030000 (Recurrent Ovarian Carcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs